Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.
2.

A Multicenter Pragmatic Interrupted Time Series Analysis of Chlorhexidine Gluconate Bathing in Community Hospital Intensive Care Units.

Dicks KV, Lofgren E, Lewis SS, Moehring RW, Sexton DJ, Anderson DJ.

Infect Control Hosp Epidemiol. 2016 Jul;37(7):791-7. doi: 10.1017/ice.2016.23. Epub 2016 Feb 10.

PMID:
26861417
3.
4.

The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial.

Climo MW, Sepkowitz KA, Zuccotti G, Fraser VJ, Warren DK, Perl TM, Speck K, Jernigan JA, Robles JR, Wong ES.

Crit Care Med. 2009 Jun;37(6):1858-65. doi: 10.1097/CCM.0b013e31819ffe6d.

PMID:
19384220
5.

Impact of chlorhexidine bathing on hospital-acquired infections among general medical patients.

Kassakian SZ, Mermel LA, Jefferson JA, Parenteau SL, Machan JT.

Infect Control Hosp Epidemiol. 2011 Mar;32(3):238-43. doi: 10.1086/658334.

PMID:
21460508
6.

The effects of chlorhexidine gluconate bathing on health care-associated infection in intensive care units: A meta-analysis.

Kim HY, Lee WK, Na S, Roh YH, Shin CS, Kim J.

J Crit Care. 2016 Apr;32:126-37. doi: 10.1016/j.jcrc.2015.11.011. Epub 2015 Dec 2. Review.

PMID:
26705765
7.

Reduction in hospital-associated methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus with daily chlorhexidine gluconate bathing for medical inpatients.

Lowe CF, Lloyd-Smith E, Sidhu B, Ritchie G, Sharma A, Jang W, Wong A, Bilawka J, Richards D, Kind T, Puddicombe D, Champagne S, Leung V, Romney MG.

Am J Infect Control. 2017 Mar 1;45(3):255-259. doi: 10.1016/j.ajic.2016.09.019. Epub 2016 Dec 8.

PMID:
27938986
8.

Impact of daily bathing with chlorhexidine gluconate on ventilator associated pneumonia in intensive care units: a meta-analysis.

Chen W, Cao Q, Li S, Li H, Zhang W.

J Thorac Dis. 2015 Apr;7(4):746-53. doi: 10.3978/j.issn.2072-1439.2015.04.21.

9.

Chlorhexidine bathing and health care-associated infections among adult intensive care patients: a systematic review and meta-analysis.

Frost SA, Alogso MC, Metcalfe L, Lynch JM, Hunt L, Sanghavi R, Alexandrou E, Hillman KM.

Crit Care. 2016 Nov 23;20(1):379.

10.

Chlorhexidine Bathing Effects on Health-Care-Associated Infections.

Denny J, Munro CL.

Biol Res Nurs. 2017 Mar;19(2):123-136. doi: 10.1177/1099800416654013. Epub 2016 Jul 26. Review.

PMID:
27306279
11.

Reconsidering contact precautions for endemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.

Morgan DJ, Murthy R, Munoz-Price LS, Barnden M, Camins BC, Johnston BL, Rubin Z, Sullivan KV, Shane AL, Dellinger EP, Rupp ME, Bearman G.

Infect Control Hosp Epidemiol. 2015 Oct;36(10):1163-72. doi: 10.1017/ice.2015.156. Epub 2015 Jul 3.

PMID:
26138329
12.

The efficacy of daily chlorhexidine bathing for preventing healthcare-associated infections in adult intensive care units.

Huang HP, Chen B, Wang HY, He M.

Korean J Intern Med. 2016 Nov;31(6):1159-1170. Epub 2016 Apr 6. Review.

13.

Implementation of daily chlorhexidine bathing to reduce colonization by multidrug-resistant organisms in a critical care unit.

Musuuza JS, Sethi AK, Roberts TJ, Safdar N.

Am J Infect Control. 2017 Sep 1;45(9):1014-1017. doi: 10.1016/j.ajic.2017.02.038. Epub 2017 Apr 18.

PMID:
28431846
14.

Daily bathing with chlorhexidine-based soap and the prevention of Staphylococcus aureus transmission and infection.

Viray MA, Morley JC, Coopersmith CM, Kollef MH, Fraser VJ, Warren DK.

Infect Control Hosp Epidemiol. 2014 Mar;35(3):243-50. doi: 10.1086/675292. Epub 2014 Jan 24.

15.
16.

Impact of chlorhexidine-impregnated washcloths on reducing incidence of vancomycin-resistant enterococci colonization in hematology-oncology patients.

Bass P, Karki S, Rhodes D, Gonelli S, Land G, Watson K, Spelman D, Harrington G, Kennon J, Cheng AC.

Am J Infect Control. 2013 Apr;41(4):345-8. doi: 10.1016/j.ajic.2012.04.324. Epub 2012 Sep 11.

PMID:
22980512
17.

Evaluation of contact precautions for methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.

Bardossy AC, Alsafadi MY, Starr P, Chami E, Pietsch J, Moreno D, Johnson L, Alangaden G, Zervos M, Reyes K.

Am J Infect Control. 2017 Dec 1;45(12):1369-1371. doi: 10.1016/j.ajic.2017.06.017. Epub 2017 Aug 24.

PMID:
28843943
18.

Elimination of Routine Contact Precautions for Endemic Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus: A Retrospective Quasi-Experimental Study.

Martin EM, Russell D, Rubin Z, Humphries R, Grogan TR, Elashoff D, Uslan DZ.

Infect Control Hosp Epidemiol. 2016 Nov;37(11):1323-1330. Epub 2016 Jul 26.

PMID:
27457254
19.

Prevalence of colonization and infection with methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus and of Clostridium difficile infection in Canadian hospitals.

Simor AE, Williams V, McGeer A, Raboud J, Larios O, Weiss K, Hirji Z, Laing F, Moore C, Gravel D; Community and Hospital Infection Control Association–Canada.

Infect Control Hosp Epidemiol. 2013 Jul;34(7):687-93. doi: 10.1086/670998. Epub 2013 May 13.

PMID:
23739072
20.

Modifying the risk: once-a-day bathing "at risk" patients in the intensive care unit with chlorhexidine gluconate.

Armellino D, Woltmann J, Parmentier D, Musa N, Eichorn A, Silverman R, Hirschwerk D, Farber B.

Am J Infect Control. 2014 May;42(5):571-3. doi: 10.1016/j.ajic.2013.12.026.

PMID:
24773800

Supplemental Content

Support Center